Benzinga's Top Upgrades (TRN, ANF, CAM, GSK)

Trinity Industries Inc TRN was upgraded by BB&T Capital from "hold" to "buy." TRN's shares closed at $30.46 on Friday. TRN's trailing-twelve-month revenue is $2.05 billion. Wells Fargo upgraded Abercrombie & Fitch Co ANF from "market perform" to "outperform." ANF's shares closed at $54.89 on Friday. Abercrombie & Fitch's trailing-twelve-month revenue is $3.26 billion. RBC Capital upgraded Cameron International Corporation CAM from “sector perform” to “outperform.” CAM's shares closed at $56.54 on Friday. Cameron International's trailing-twelve-month ROE is 13.54%. Analysts at Exane BNP Paribas upgraded GlaxoSmithKline plc GSK from “neutral” to “outperform.” GSK's shares closed at $37.75 on Friday. GlaxoSmithKline's trailing-twelve-month operating margin is 32.35%. More Analyst Ratings here